Objective Nine-valent human papillomavirus (9vHPV) vaccine efficacy against disease and
cervical surgeries related to all nine vaccine components was assessed compared with a …

Human papillomavirus (HPV), a member of the Papillomaviridae family, is a small (8kb),
nonenveloped, double‐stranded DNA virus. HPV has a predilection for infecting cutaneous …

Background: Recent studies have shown preliminary evidence that vaccination against
human papillomavirus (HPV) could decrease the risk of persistent/recurrent HSIL in women …

Undoubtedly, diagnosing and managing infections is one of the most challenging issues for
orofacial clinicians. As a result of the diversity of symptoms, complicated behavior, and …

Simple Summary This review discusses the timeline and development of the recommended
screening tests, diagnosis system, and therapeutics implemented in clinics for precancer …

Vaccines against human papillomavirus (HPV) are available in Europe since 2006. They
have been highly effective in preventing infection and disease caused by the vaccine types …

Objective: To date, no data supports the execution of vaccination after hysterectomy for high-
grade cervical intraepithelial neoplasia (CIN2+) and early-stage cervical cancer. We aim to …

Background High-risk human papilloma viruses (HPV) are a causative agent of anogenital
and oropharyngeal cancers. Patients treated for a preinvasive or invasive HPV-associated …

Individuals with human papillomavirus (HPV)-related disease remain at risk for subsequent
HPV infection and related disease after treatment of specific lesions. Prophylactic HPV …

The high prevalence of human papillomavirus (HPV), the most common sexually transmitted
infection, arises from the coexistence of over 200 genetically distinct types. Accurately …